Excerpt: “For more than a year, the Committee has been investigating potential breakdowns in the controlled substances supply chain which may have contributed to the nation’s opioid epidemic. Pharmaceutical manufacturers play a unique and critical role in this supply chain by researching and developing products for the consumer market as well as marketing such products after obtaining approval from the Food and Drug Administration (FDA).”
To read a copy of the letter to Insys Therapeutics, Inc., click here.
To read a copy of the letter to Mallinckrodt Pharmaceuticals, click here.
To read a copy of the letter to Purdue Pharma L.P., click here.